The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Biology of Osteoclast Activation in Cancer
Abstract
Bone is a frequent site of cancer metastasis. Bone metastases can result in bone destruction or new bone formation. Bone destruction is mediated by factors produced or induced by tumor cells that stimulate formation and activation of osteoclasts, the normal bone-resorbing cells. Local bone destruction also occurs in patients with osteoblastic metastases and may precede or occur simultaneously with increased bone formation. Several factors, including interleukin (IL)-1, IL-6, receptor activator of NF-kappaB (RANK) ligand, parathyroid hormone-related protein (PTHrP), and macrophage inflammatory protein-1-alpha (MIP-1α), have been implicated as factors that enhance osteoclast formation and bone destruction in patients with neoplasia. PTHrP seems to be the major factor produced by breast cancer cells that induces osteoclast formation through upregulation of RANK ligand. Enhanced RANK ligand expression also plays an important role in bone destruction in patients with myeloma. RANK ligand can act to enhance the effects of other factors produced by myeloma cells or in response to myeloma cells, such as MIP-1α and/or IL-6, to induce osteoclast formation. Understanding of the molecular mechanisms responsible for osteoclast activation in osteolytic metastases should lead to development of novel therapeutic approaches for this highly morbid and potentially fatal complication of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and Expression
Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., et al. (1987) · Science · doi:10.1126/science.3616618 · Cited by 1,293
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 933
Osteoclastic Bone Resorption by a Polarized Vacuolar Proton Pump
Blair, H. C., Teitelbaum, S. L., Ghiselli, R., & Gluck, S. (1989) · Science · doi:10.1126/science.2528207 · Cited by 860
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775
Cell biology of the osteoclast
Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 571
Self-citationUDAGAWA, N., TAKAHASHI, N., AKATSU, T., SASAKI, T., YAMAGUCHI, A., KODAMA, H., MARTIN, T. J., & SUDA, T. (1989) · Endocrinology · doi:10.1210/endo-125-4-1805 · Cited by 492
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
Self-citationBataille, R., Jourdan, M., Zhang, X. G., & Klein, B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114392 · Cited by 479
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Pfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 431
Choi, S. J., Cruz, J. C., Craig, F., Chung, H., Devlin, R. D., Roodman, G. D., & Alsina, M. (2000) · Blood · doi:10.1182/blood.v96.2.671 · Cited by 408
Self-citationProduction of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma Cells
Garrett, I. R., Durie, B. G. M., Nedwin, G. E., Gillespie, A., Bringman, T., Sabatini, M., Bertolini, D. R., & Mundy, G. R. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708273170902 · Cited by 373
Sly, W. S., Whyte, M. P., Sundaram, V., Tashian, R. E., Hewett-Emmett, D., Guibaud, P., Vainsel, M., Baluarte, H. J., Gruskin, A., Al-Mosawi, M., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130302 · Cited by 330
Han, J.-H., Choi, S. J., Kurihara, N., Koide, M., Oba, Y., & Roodman, G. D. (2001) · Blood · doi:10.1182/blood.v97.11.3349 · Cited by 328
Self-citationKodama, H., Nose, M., Niida, S., & Yamasaki, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.5.1291 · Cited by 281
Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma
Bataille, R., Barlogie, B., Lu, Z., Rossi, J., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J., & Klein, B. (1995) · Blood · doi:10.1182/blood.v86.2.685.bloodjournal862685 · Cited by 269
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Self-citationImmunohistochemical localization of parathyroid hormone-related protein in human breast cancer.
Southby, J., Kissin, M. W., Danks, J. A., Hayman, J., Moseley, J. M., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1990) · PubMed · Cited by 249
Tsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 238
Direct resorption of bone by human breast cancer cells in vitro
EILON, G., & MUNDY, G. R. (1978) · Nature · doi:10.1038/276726a0 · Cited by 235
Michigami, T., Shimizu, N., Williams, P. J., Niewolna, M., Dallas, S. L., Mundy, G. R., & Yoneda, T. (2000) · Blood · doi:10.1182/blood.v96.5.1953 · Cited by 214
Black, K., Garrett, I. R., & Mundy, G. R. (1991) · Endocrinology · doi:10.1210/endo-128-5-2657 · Cited by 199
Production of interleukin-1 by bone marrow myeloma cells
Cozzolino, F., Torcia, M., Aldinucci, D., Rubartelli, A., Miliani, A., Shaw, A., Lansdorp, P., & Di Guglielmo, R. (1989) · Blood · doi:10.1182/blood.v74.1.380.380 · Cited by 185
Barillé, S., Akhoundi, C., Collette, M., Mellerin, M.-P., Rapp, M.-J., Harousseau, J.-L., Bataille, R., & Amiot, M. (1997) · Blood · doi:10.1182/blood.v90.4.1649 · Cited by 183
Wani, M. R. (1999) · Endocrinology · doi:10.1210/en.140.4.1927 · Cited by 172
Scanning electron microscopy in bone pathology: review of methods, potential and applications.
BOYDE, A., Maconnachie, E., Reid, S. A., Delling, G., & Mundy, G. R. (1986) · PubMed · Cited by 159
Johnson, R., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1989) · Endocrinology · doi:10.1210/endo-124-3-1424 · Cited by 152
Self-citationTeoh, G., & Anderson, K. C. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70413-5 · Cited by 146
Carbonic Anhydrase and Bone Remodeling: Sulfonamide Inhibition of Bone Resorption in Organ Culture
Minkin, C., & Jennings, J. M. (1972) · Science · doi:10.1126/science.176.4038.1031 · Cited by 145
Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma
Kawano, M., Tanaka, H., Ishikawa, H., Nobuyoshi, M., Iwato, K., Asaoku, H., Tanabe, O., & Kuramoto, A. (1989) · Blood · doi:10.1182/blood.v73.8.2145.2145 · Cited by 131
Devlin, R. D., Reddy, S. V., Savino, R., Ciliberto, G., & Roodman, G. D. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.393 · Cited by 126
Self-citationParathyroid hormone‐related protein in hypercalcaemia associated with haematological malignancy
Firkin, F. C., Seymour, J. F., Watson, A., et al. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1819.x · Cited by 118
Hjertner, Ø., Torgersen, M. L., Seidel, C., Hjorth‐Hansen, H., Waage, A., Børset, M., & Sundan, A. (1999) · Blood · doi:10.1182/blood.v94.11.3883 · Cited by 111
Mechanisms of Bone Lesions in Multiple Myeloma
Bataille, R., Chappard, D., & Klein, B. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30345-9 · Cited by 105
Anderson, R. E., Schraer, H., & Gay, C. V. (1982) · The Anatomical Record · doi:10.1002/ar.1092040103 · Cited by 97
Chikatsu, N., Takeuchi, Y., Tamura, Y., Fukumoto, S., Yano, K., Tsuda, E., Ogata, E., & Fujita, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2008 · Cited by 95
Pederson, L. G., Winding, B., Foged, N. T., Spelsberg, T. C., & Oursler, M. J. (1999) · PubMed · Cited by 92
Sati, H. I. A., Greaves, M., Apperley, J. F., Russell, R. G. G., & Croucher, P. I. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01193.x · Cited by 91
Correlation Between Bone Metabolic Markers and Bone Scan in Prostatic Cancer
Maeda, H. A., Koizumi, M., Yoshimura, K., Yamauchi, T., Kawai, T., & Ogata, E. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65196-6 · Cited by 90
Bisphosphonates in prostate carcinoma
Adami, S. (1997) · Cancer · Cited by 89
Interleukin‐1 in multiple myeloma: producer cells and their role in the control of IL‐6 production
Costes, V., Portier, M., Lu, Z., Rossi, J., Bataille, R., & Klein, B. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01101.x · Cited by 88
THE ROLE OF INTERLEUKIN-1β IN THE PATHOGENESIS OF MULTIPLE MYELOMA
Lust, J. A., & Donovan, K. A. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70115-5 · Cited by 85
Lacy, M. Q., Donovan, K. A., Heimbach, J. K., Ahmann, G. J., & Lust, J. A. (1999) · Blood · doi:10.1182/blood.v93.1.300 · Cited by 81
Barillé‐Nion, S., Bataille, R., Rapp, M., Harousseau, J., & Amiot, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5723 · Cited by 80
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis
Hofbauer, L. C., & Heufelder, A. E. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390152 · Cited by 74
Uy, H. L., Mundy, G. R., Boyce, B. F., Story, B. M., Dunstan, C. R., Yin, J. J., Roodman, G. D., & Guise, T. A. (1997) · PubMed · Cited by 55
Self-citationGrano, M., Mori, G., Minielli, V., Cantatore, F. P., Colucci, S., & Zallone, A. Z. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2569 · Cited by 54
Ballester, O., Moscinski, L. C., Lyman, G. H., Chaney, J., Saba, H., Spiers, A. S. D., & Klein, C. (1994) · Blood · doi:10.1182/blood.v83.7.1903.1903 · Cited by 49
Frolik, C. A., Cain, R. L., Sato, M., Harvey, A. K., Chandrasekhar, S., Black, E. C., Tashjian, A. H., & Hock, J. M. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.2.163 · Cited by 47
Thomas, X., Anglaret, B., Magaud, J., Epstein, J., & Archimbaud, E. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809059251 · Cited by 43
Akatsu, T., Ono, K., Katayama, Y., Tamura, T., Nishikawa, M., Kugai, N., Yamamoto, M., & Nagata, N. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.400 · Cited by 32
Myeloma Phenotype: Clues To Disease Origin and Manifestation
Epstein, J. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30342-3 · Cited by 29
Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis
Matsumoto, H., Tamura, M., Denhardt, D. T., Obinata, M., & Noda, M. (1995) · Endocrinology · doi:10.1210/en.136.9.4084 · Cited by 23
Serum pyridinoline crosslinks as markers of tumour‐induced bone resorption
Nemoto, R., Nakamura, I., Nishijima, Y., et al. (1997) · British Journal of Urology · doi:10.1046/j.1464-410x.1997.00237.x · Cited by 20
Cited by
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Self-citationTian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Hao, Y., Baker, D., & ten Dijke, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112767 · Cited by 1,142
The molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Multiple myeloma: evolving genetic events and host interactions
Kuehl, W. M., & Bergsagel, P. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc746 · Cited by 818
Metadata
- Authors
- Roodman, G. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-08-01
- Volume
- 19
- Issue
- 15
- Pages
- 3562-3571
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1944909911
- Cited by
- 306
- References
- 60
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.